The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model. (November 2021) - Eggermont, Alexander M.M.; Bellomo, Domenico; Dwarkasing, Jvalini; Meerstein-Kessel, Lisette; Meves, Alexander